CRP and cancer: Second, the inflammatory cytokines that drive CRP production, such as IL-6 and TNF-α, have been shown4, 5to promote epithelial-mesenchymal transition (EMT), a process through which cancer cells acquire migratory and invasive properties necessary for metastasis.